All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@drspf's steroid injection claims for acne, fact-checked

Dr. Daniel Sugai

TikTok creator

331.5K viewsWatch on TikTok→

Quick answer

Intralesional triamcinolone acetonide, typically diluted to 2.5-5 mg/mL, is a standard dermatologic procedure for rapid reduction of nodulocystic acne lesions, with evidence supporting inflammatory reduction within 24-72 hours. The creator accurately emphasized concentration-appropriate dilution as the key variable controlling skin atrophy risk, which is the most common adverse outcome of this procedure. Recurrent hormonal cystic acne in women requires systemic management and is not appropriately addressed by repeat intralesional injection alone.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @drspf actually say?

The creator, who presents as a dermatologist, pitched intralesional Kenalog (triamcinolone acetonide) as a fast fix for a single stubborn cystic pimple before a big event. The pitch is reasonable on its face. They said relief comes "within the next 24 to 48 hours," warned that improper dilution causes skin atrophy, and pushed back against using injections as a long-term strategy. They closed by urging viewers to see a dermatologist for actual acne control, not just spot treatments.

Worth noting: the video was categorized under TRT and testosterone replacement therapy. That categorization is wrong. This video is about dermatology, not hormone optimization. There is no testosterone content here. That mislabeling matters when you're trying to understand what kind of professional is speaking and in what context.

Does the science back this up?

Yes, largely. Intralesional corticosteroid injections for nodulocystic acne are well-established in dermatology. The mechanism is straightforward: triamcinolone suppresses local inflammation by inhibiting prostaglandin synthesis and reducing vascular permeability. The 24-48 hour timeline the creator cites is consistent with clinical observation, though most literature describes significant flattening within 24-72 hours depending on lesion size and concentration used.

A review by Levine and Rasmussen (2000, Dermatologic Surgery) confirmed that intralesional triamcinolone at concentrations of 2.5-5 mg/mL is effective for rapid reduction of inflammatory nodules with minimal systemic absorption. The skin atrophy warning is also evidence-based: Friedman et al. (2010, Journal of the American Academy of Dermatology) documented that concentrations above 5 mg/mL increase atrophy risk significantly, which is exactly what the creator flagged about improper dilution.

What did they get wrong (or right)?

They got the core clinical content right. The dilution warning is genuinely important and under-discussed in social media skincare content. Most injector-related atrophy cases involve concentration errors, not technique errors, so flagging that specifically deserves credit.

What they glossed over: the 24-48 hour timeline can be optimistic for deeper nodules. Some lesions, particularly larger cysts with significant fibrotic walls, may take 5-7 days for meaningful reduction. Telling someone with an event in 24 hours to get a shot that morning is not always going to deliver the promised result. The creator also did not mention the risk of post-inflammatory hyperpigmentation that can follow rapid lesion collapse in darker skin tones, a clinically significant omission for a broad TikTok audience.

The hormonal acne section was accurate, correctly flagging the jawline pattern in women ages 25-40 as a hormonal signal requiring systemic management rather than repeated injections.

What should you actually know?

If you have a cystic lesion and an event, here is the practical reality. Intralesional triamcinolone works, but timing matters. An injection 3-5 days before an event gives better odds than the morning before. The standard concentration used in most dermatology practices is 2.5-5 mg/mL; anything higher is where atrophy risk climbs. A 30-gauge needle is appropriate, as the creator stated, and the injection volume should be small enough to blanch the lesion slightly without flooding adjacent tissue.

Do not attempt to replicate this at home. Triamcinolone is a prescription medication and intralesional injection requires anatomical knowledge. Misplaced injections near the eye or over temporal vessels carry real risk. The creator is right that this is a dermatologist visit, not a DIY procedure.

For anyone with recurring jawline or chin cysts, hormonal workup and long-term management options like spironolactone, oral contraceptives, or isotretinoin are far more appropriate than a standing monthly injection appointment. Injections are a rescue tool, not a treatment plan.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @drspf's steroid injection claims for acne, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@drspf's steroid injection claims for acne, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Intralesional triamcinolone acetonide, typically diluted to 2.

FormBlends verdict

Intralesional triamcinolone acetonide, typically diluted to 2.5-5 mg/mL, is a standard dermatologic procedure for rapid reduction of nodulocystic acne lesions, with evidence supporting inflammatory reduction within 24-72 hours. The creator accurately emphasized concentration-appropriate dilution as the key variable controlling skin atrophy risk, which is the most common adverse outcome of this procedure. Recurrent hormonal cystic acne in women requires systemic management and is not appropriately addressed by repeat intralesional injection alone.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Intralesional triamcinolone acetonide, typically diluted to 2.5-5 mg/mL, is a standard dermatologic procedure for rapid reduction of nodulocystic acne lesions, with evidence supporting inflammatory reduction within 24-72 hours. The creator accurately emphasized concentration-appropriate dilution as the key variable controlling skin atrophy risk, which is the most common adverse outcome of this procedure. Recurrent hormonal cystic acne in women requires systemic management and is not appropriately addressed by repeat intralesional injection alone.
  • Intralesional triamcinolone at 2.5-5 mg/mL is clinically validated for nodulocystic acne, with inflammation reduction documented within 24-72 hours in most cases.
  • Concentration above 5 mg/mL significantly increases skin atrophy risk; dilution accuracy is the single most important technical variable in this procedure.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Intralesional triamcinolone at 2.5-5 mg/mL is clinically validated for nodulocystic acne, with inflammation reduction documented within 24-72 hours in most cases.
  • Concentration above 5 mg/mL significantly increases skin atrophy risk; dilution accuracy is the single most important technical variable in this procedure.
  • The 24-48 hour relief window is optimistic for large or deep cysts; plan for at least 3-5 days before a high-stakes event for more reliable results.
  • Post-inflammatory hyperpigmentation risk after rapid lesion collapse was not mentioned in the video and is clinically relevant for patients with Fitzpatrick skin types III-VI.
  • Intralesional injections are a prescription procedure requiring medical training; there is no safe at-home equivalent.
  • Recurrent jawline cystic acne in women ages 25-40 warrants hormonal evaluation and systemic therapy, not a repeat injection schedule.
  • This video was miscategorized as TRT content; it contains no testosterone or hormone optimization content and should be evaluated as dermatology only.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Daniel Sugai · TikTok creator

331.5K views on this video

POV: You have a painful cystic pimple before an event. Don’t pop it! ➡️ IL Kenalog ➡️ Inflammation down ➡️ Relief fast 💪 #intralesionalkenalog #steroidshot #cysticacne #drsugaiskincare #acne

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Daniel Sugai, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.